Works matching IS 03125963 AND DT 2020 AND VI 59 AND IP 2

Results: 15

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
Published in:
2020
By:
- Krebs-Brown, Axel;
- Munafo, Alain;
- Gaikwad, Sumedh;
- Urgatz, Bogumila;
- Castello-Bridoux, Claire
Publication type:
Letter
Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
Published in:
2020
By:
- Concordet, Didier;
- Gandia, Peggy;
- Montastruc, Jean-Louis;
- Bousquet-Mélou, Alain;
- Lees, Peter;
- Ferran, Aude A.;
- Toutain, Pierre-Louis
Publication type:
Letter
Comment on "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?".
Published in:
2020
By:
- Yu, Yang;
- Maliepaard, Marc
Publication type:
Letter
Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
Published in:
2020
By:
- Nicolas, Patrick
Publication type:
Letter
Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".
Published in:
2020
By:
- Concordet, D.;
- Gandia, P.;
- Montastruc, J. L.;
- Bousquet-Mélou, A.;
- Lees, P.;
- Ferran, A. A.;
- Toutain, P. L.
Publication type:
Letter
Authors' Reply to Yu et al.: "Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?".
Published in:
2020
By:
- Concordet, Didier;
- Gandia, Peggy;
- Montastruc, Jean-Louis;
- Bousquet-Mélou, Alain;
- Lees, Peter;
- Ferran, Aude A.;
- Toutain, Pierre-Louis
Publication type:
Letter
Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.
Published in:
2020
By:
- Haahr, Hanne;
- Heise, Tim
Publication type:
journal article
Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review.
Published in:
2020
By:
- Havens, Joshua P.;
- Podany, Anthony T.;
- Scarsi, Kimberly K.;
- Fletcher, Courtney V.
Publication type:
journal article
Drug Exposure to Establish Pharmacokinetic-Response Relationships in Oncology.
Published in:
2020
By:
- Solans, Belén P.;
- Garrido, María Jesús;
- Trocóniz, Iñaki F.
Publication type:
journal article
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Published in:
2020
By:
- Janssen, Julie M.;
- Dorlo, T. P. C.;
- Niewerth, D.;
- Wilhelm, A. J.;
- Zwaan, C. M.;
- Beijnen, J. H.;
- Attarbaschi, A.;
- Baruchel, A.;
- Fagioli, F.;
- Klingebiel, T.;
- De Moerloose, B.;
- Palumbo, G.;
- von Stackelberg, A.;
- Kaspers, G. J. L.;
- Huitema, A. D. R.
Publication type:
journal article
Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus.
Published in:
2020
By:
- Vet, Nienke J.;
- de Winter, Brenda C. M.;
- Koninckx, Muriel;
- Boeschoten, Shelley A.;
- Boehmer, Annemie L. M.;
- Verhallen, Jacintha T.;
- Plötz, Frans B.;
- Vaessen-Verberne, Anja A.;
- van der Nagel, Bart C. H.;
- Knibbe, Catherijne A. J.;
- Buysse, Corinne M. P.;
- de Wildt, Saskia N.;
- Koch, Birgit C. P.;
- de Hoog, Matthijs
Publication type:
journal article
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.
Published in:
2020
By:
- Chelle, Pierre;
- Yeung, Cindy H. T.;
- Croteau, Stacy E.;
- Lissick, Jennifer;
- Balasa, Vinod;
- Ashburner, Christina;
- Park, Young Shil;
- Bonanad, Santiago;
- Megías-Vericat, Juan Eduardo;
- Nagao, Azusa;
- Wynn, Tung;
- Corrales-Medina, Fernando;
- Tran, Huyen;
- Sharathkumar, Anjali;
- Chitlur, Meera;
- Sarmiento, Samuel;
- Edginton, Andrea;
- Iorio, Alfonso
Publication type:
journal article
Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects.
Published in:
2020
By:
- Pérez-Ruixo, Carlos;
- Pérez-Blanco, Jonás Samuel;
- Chien, Caly;
- Yu, Margaret;
- Ouellet, Daniele;
- Pérez-Ruixo, Juan-José;
- Ackaert, Oliver
Publication type:
journal article
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies.
Published in:
2020
By:
- Ogasawara, Ken;
- Newhall, Kathryn;
- Maxwell, Stephen E.;
- Dell'Aringa, Justine;
- Komashko, Vitalina;
- Kilavuz, Nurgul;
- Delarue, Richard;
- Czuczman, Myron;
- Sternas, Lars;
- Rose, Shelonitda;
- Beach, C. L.;
- Novick, Steven;
- Zhou, Simon;
- Palmisano, Maria;
- Li, Yan
Publication type:
journal article
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Published in:
2020
By:
- Hartman, Stan J. F.;
- Brüggemann, Roger J.;
- Orriëns, Lynn;
- Dia, Nada;
- Schreuder, Michiel F.;
- de Wildt, Saskia N.
Publication type:
journal article

Works matching IS 03125963 AND DT 2020 AND VI 59 AND IP 2

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Comment on "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?".

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".

Authors' Reply to Yu et al.: "Levothyrox<sup>®</sup> New and Old Formulations: Are They Switchable for Millions of Patients?".

Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.

Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review.

Drug Exposure to Establish Pharmacokinetic-Response Relationships in Oncology.

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus.

Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.

Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects.

Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies.

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.